Search Results 1061-1070 of 19349 for autoimmune hepatitis
Subject has active, known or suspected autoimmune disease, including systemic lupus ... auto-immune hepatitis. Subjects with Type I diabetes mellitus ...
Somatostatin analog therapy for severe polycystic liver disease: Results after 2 years. Nephrology Dialysis Transplantation. 2012; doi:10.1093/ndt/gfs152 ...
Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers are also making ...
Liver disease—Use with caution. The effects may be increased because of slower removal of the medicine from the body. Liver disease, mild to moderate—Use of ...
... autoimmune diseases not relevant to the groups defined in this study. Patients with a history of chronic infections, including tuberculosis or hepatitis B or C.
Chronic pruritus of moderate-to-severe severity in the setting of intrahepatic or extrahepatic cholestatic liver disease. Chronic is defined as greater than ...
High blood pressure (hypertension) and chronic kidney disease; Kidney disease and chronic liver disease. Mayo Clinic also heads the Nephrology Collaborative ...
Other hepatic conditions ( e.g., primary sclerosing cholangitis [PSC], alcoholic liver disease, autoimmune hepatitis, non-alcoholic steatohepatitis [NASH] ...
If you have liver disease, avoid taking valerian. And because valerian can make you drowsy, avoid driving or operating dangerous machinery after taking it ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.